Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States
ConclusionsPatients initiating injectable therapies had greater persistence and compliance at 2 years than those initiating oral therapies. Patients initiating an every-6-month injection had significantly higher persistence compared with those initiating more frequently dosed (e.g., daily and weekly) oral or injectable agents.
Source: Archives of Orthopaedic and Trauma Surgery - Category: Orthopaedics Source Type: research
More News: Evista | Insurance | Medicare | Orthopaedics | Osteoporosis | Reclast | Study | Women | Xgeva | Zometa